You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰格醫藥(300347.SZ):聘任吳灝為公司聯席總裁
格隆匯 08-10 16:42

格隆匯8月10日丨泰格醫藥(300347.SZ)公佈,公司2021810日召開第四屆董事會第十七次會議,審議通過了《關於聘任公司聯席總裁的議案》。為適應公司的發展需要,完善公司治理結構根據《公司法》、《證券法》等法律、法規、規範性文件及《公司章程》的有關規定,經董事長葉小平提名,董事會提名委員會審議通過,董事會同意聘任吳灝為公司聯席總裁任期自本次會議審議通過之日起至第四屆董事會屆滿之日止

公吿顯示,吳灝男,中國籍,19677月生,研究生學歷吳灝17醫藥行業從業經驗,19948-199910月任先靈葆雅製藥有限公司銷售經理、產品/項目經理。199910-200212月任上海羅氏製藥有限公司產品組經理。20031-20077月任衞材(中國)製藥有限公司市場部總監。20078-20091月任賽生國際製藥有限公司市場/事業拓展部總監。20103-20201月任美信保險經紀(上海)有限公司總經理。20201月加入泰格醫藥。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account